XML 31 R8.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2015
Sep. 24, 2014
Cash flows from operating activities:    
Net income $ 27,217 $ 23,047
Adjustments to reconcile net income to cash flows provided by operating activities:    
Depreciation and amortization 15,760 15,704
Operating (gains), losses and other charges, net 1,722 1,049
Amortization of deferred financing costs 366 362
Loss (gain) on early extinguishments of debt 260 (54)
Loss on change in the fair value of interest rate caps 0 11
Deferred income tax expense 9,013 8,118
Share-based compensation 5,505 2,993
Decrease (increase) in assets:    
Receivables 4,626 2,325
Inventories 44 138
Other current assets (358) 1,089
Other assets 726 (1,668)
Increase (decrease) in liabilities:    
Accounts payable 1,134 1,797
Accrued salaries and vacations (2,278) (620)
Accrued taxes 1,389 1,753
Other accrued liabilities (6,655) (5,437)
Other noncurrent liabilities and deferred credits (1,544) (2,366)
Net cash flows provided by operating activities 56,927 48,241
Cash flows from investing activities:    
Capital expenditures (18,432) (17,880)
Acquisition of restaurants and real estate (2,330) 0
Proceeds from disposition of property 0 61
Collections on notes receivable 1,359 1,788
Issuance of notes receivable (1,151) (1,167)
Net cash flows used in investing activities (20,554) (17,198)
Cash flows from financing activities:    
Revolver borrowings 167,500 22,200
Revolver payments (102,750) (20,450)
Long-term debt payments (57,486) (5,340)
Proceeds from exercise of stock options 471 970
Tax withholding on share-based payments (982) (419)
Tax benefit for share-based compensation 976 627
Deferred financing costs (1,265) 0
Purchase of treasury stock (37,310) (32,073)
Net bank overdrafts 0 1,949
Net cash flows used in financing activities (30,846) (32,536)
Increase (decrease) in cash and cash equivalents 5,527 (1,493)
Cash and cash equivalents at beginning of period 3,074 2,943
Cash and cash equivalents at end of period $ 8,601 $ 1,450